Anavex3-71 Capsules
Schizophrenia
Anavex Life Sciences Corp.Phase 2Active
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 65/ 100
Competitive context
135 Active assets in the Schizophrenia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
PALIPERIDONE PALMITATE , (R)- Jiangsu Province Nanjing Brain Hospital | Phase 4 | BBB |
TROSPIUM European Group for Research In Schizophrenia | Phase 4 | BBB |
Opc-34712 Humanis Saglık Anonim Sirketi | Phase 4 | BBB |
Bitopertin Hoffmann-La Roche | Phase 3 | BBB |
Iloperidone Vanda Pharmaceuticals | Phase 4 | BBB |
View all 50 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →